D. Adelstein

发表

An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer.

J. Ensley, D. Schuller, H. Wagner, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

NCCN Guidelines ® Insights Head and Neck Cancers , Version 2 . 2017 Featured Updates to the NCCN Guidelines

Bharat B. Mittal, Jill Gilbert, Loren K. Mell, 2017 .

Adjuvant Chemoradiation After Surgical Resection in Elderly Patients With High-Risk Squamous Cell Carcinoma of the Head and Neck: A National Cancer Database Analysis.

B. Burkey, C. Reddy, S. Koyfman, 2017, International journal of radiation oncology, biology, physics.

Risk factors for hypopharyngeal/upper esophageal stricture formation after concurrent chemoradiation

R. Butler, M. Strome, R. Esclamado, 2006, Head & neck.

Ability of positron emission tomography to detect residual neck node disease in patients with head and neck squamous cell carcinoma after definitive chemoradiotherapy.

L. Rybicki, M. Strome, R. Esclamado, 2007, Archives of otolaryngology--head & neck surgery.

Transoral resection of pharyngeal cancer: Summary of a National Cancer Institute Head and Neck Cancer Steering Committee Clinical Trials Planning Meeting, November 6–7, 2011, Arlington, Virginia

J. Manola, E. Genden, G. Weinstein, 2012, Head & neck.

Who merits a neck dissection after definitive chemoradiotherapy for N2–N3 squamous cell head and neck cancer?

L. Rybicki, M. Strome, R. Esclamado, 2003, Head & neck.

P53 and Ki‐67 as Outcome Predictors for Advanced Squamous Cell Cancers of the Head and Neck Treated With Chemoradiotherapy

J. Myles, M. Secic, D. Adelstein, 2001, The Laryngoscope.

Mature results of a Phase III randomized trial comparing concurrent chemoradiotherapy with radiation therapy alone in patients with Stage III and IV squamous cell carcinoma of the head and neck

M. Secic, M. Strome, J. Saxton, 2000, Cancer.

Solitary dural metastasis at presentation in a patient with untreated human papillomavirus–associated squamous cell carcinoma of the oropharynx

B. Burkey, S. Koyfman, D. Adelstein, 2014, Head & neck.

Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology.

Yoshimi Anzai, Thomas Galloway, Sue S Yom, 2020, Journal of the National Comprehensive Cancer Network : JNCCN.

Enteral feeding tubes in patients undergoing definitive chemoradiation therapy for head-and-neck cancer: a critical review.

S. Koyfman, D. Adelstein, 2012, International journal of radiation oncology, biology, physics.

Effect of human papillomavirus on patterns of distant metastatic failure in oropharyngeal squamous cell carcinoma treated with chemoradiotherapy.

B. Burkey, S. Koyfman, D. Adelstein, 2015, JAMA otolaryngology-- head & neck surgery.

Radiation therapy for oropharyngeal squamous cell carcinoma: Executive summary of an ASTRO Evidence-Based Clinical Practice Guideline.

E. Sturgis, R. Tishler, J. Waldron, 2017, Practical radiation oncology.

Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial

Christopher U. Jones, E. Sturgis, P. Harari, 2019, The Lancet.

Prospective Clinical Study of Precision Oncology in Solid Tumors.

Gary W Procop, Jame Abraham, A. Khorana, 2015, Journal of the National Cancer Institute.

A phase III randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer: Preliminary results

L. Tuason, M. Strome, J. Saxton, 1997, Head & neck.

Guideline for the Use of Larynx-Preservation Strategies in the Treatment of Laryngeal Cancer

K. Ang, G. Weinstein, Snehal G. Patel, 2006 .

Oropharyngeal squamous cell carcinoma with known human papillomavirus status treated with definitive chemoradiotherapy: patterns of failure and toxicity outcomes

L. Rybicki, S. Koyfman, D. Chute, 2013, Radiation oncology.

Persistent Dysphagia After Induction Chemotherapy in Patients with Esophageal Adenocarcinoma Predicts Poor Post-Operative Outcomes

S. Murthy, L. Rybicki, G. Videtic, 2017, Journal of Gastrointestinal Cancer.

The relationship between pathologic nodal disease and residual tumor viability after induction chemotherapy in patients with locally advanced esophageal adenocarcinoma receiving a tri-modality regimen.

S. Murthy, L. Rybicki, G. Videtic, 2016, Journal of gastrointestinal oncology.

A Phase II Trial of Induction Epirubicin, Oxaliplatin, and Fluorouracil, Followed by Surgery and Postoperative Concurrent Cisplatin and Fluorouracil Chemoradiotherapy in Patients with Locoregionally Advanced Adenocarcinoma of the Esophagus and Gastroesophageal Junction

T. Rice, S. Murthy, L. Rybicki, 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

esophageal carcinoma Benefit of postoperative adjuvant chemoradiotherapy in locoregionally advanced

E. Blackstone, T. Rice, S. Murthy, 2013 .

Resectable esophageal carcinoma: local control with neoadjuvant chemotherapy and radiation therapy.

P. Kupelian, T. Rice, M. Chidel, 1999, Radiology.

Adenocarcinoma of the Esophagus and Gastroesophageal Junction Clinical and Pathologic Assessment of Response to Induction Chemotherapy

M. Sivak, T. Rice, R. Bukowski, 1994, American journal of clinical oncology.

Factors Associated with Improved Survival in Patients with Brain Metastases from Esophageal Cancer: A Retrospective Review

G. Barnett, T. Rice, M. Chidel, 2003, Technology in cancer research & treatment.

Accelerated hyperfractionated radiation, concurrent paclitaxel/cisplatin chemotherapy and surgery for stage III non-small cell lung cancer.

J. Ciezki, T. Rice, L. Rybicki, 2002, Lung cancer.

Mature results from a phase II trial of accelerated induction chemoradiotherapy and surgery for poor prognosis stage III non-small-cell lung cancer.

T. Olencki, T. Rice, L. Rybicki, 1999, American journal of clinical oncology.

Short-course induction chemoradiotherapy with paclitaxel for stage III non-small-cell lung cancer.

J. Ciezki, E. Blackstone, T. Rice, 1998, The Annals of thoracic surgery.

Accelerated induction therapy and resection for poor prognosis stage III non-small cell lung cancer.

T. Olencki, T. Rice, G. Budd, 1995, The Annals of thoracic surgery.

Disease Progression in Cutaneous Squamous Cell Carcinoma Patients With Satellitosis and In-transit Metastasis

S. Koyfman, J. Geiger, W. Bergfeld, 2021, Anticancer Research.

Utility of positron emission tomography compared with mediastinoscopy for delineating involved lymph nodes in stage III lung cancer: insights for radiotherapy planning from a surgical cohort.

T. Rice, S. Murthy, T. Mekhail, 2008, International journal of radiation oncology, biology, physics.

Efficacy of high‐dose oral leucovorin and 5‐fluorouracil in advanced colorectal carcinoma. Plasma and tissue pharmacokinetics

D. Adelstein, J. Spiess, J. Hines, 1989, Cancer.

Stage III non-small cell lung cancer and metachronous brain metastases.

G. Barnett, E. Blackstone, T. Rice, 2002, The Journal of thoracic and cardiovascular surgery.

Aggressive concurrent chemoradiotherapy and surgical resection for proximal esophageal squamous cell carcinoma

T. Rice, D. Adelstein, M. Taylor, 1994, Cancer.

The prognostic impact of level I lymph node involvement in oropharyngeal squamous cell carcinoma

B. Burkey, Kailin Yang, S. Koyfman, 2019, Head & neck.

Use of systemic therapy with definitive radiotherapy for elderly patients with head and neck cancer: A National Cancer Data Base analysis

C. Reddy, S. Koyfman, D. Adelstein, 2016, Cancer.

Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19805 patients, on behalf of MACH-NC group.

B. Jeremic, L. Collette, J. Pignon, 2021, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Gemcitabine and cisplatin in unresectable malignant mesothelioma of the pleura: a phase II study of the Southwest Oncology Group (SWOG 9810).

E. Borden, D. Petrylak, D. Adelstein, 2008, Lung cancer.

Role of positron emission tomography in management of sinonasal neoplasms--a single institution's experience.

M. Citardi, D. Adelstein, E. Lamarre, 2012, American journal of otolaryngology.

A matched comparison of human papillomavirus–induced squamous cancer of unknown primary with early oropharynx cancer

B. Burkey, C. Reddy, S. Koyfman, 2018, The Laryngoscope.

Impact of feeding tube choice on severe late dysphagia after definitive chemoradiotherapy for human papillomavirus–negative head and neck cancer

B. Burkey, C. Reddy, S. Koyfman, 2015, Head & neck.

Current Status of Clinical Trials in Head and Neck Cancer 2014

B. O'Sullivan, D. Brizel, J. Ridge, 2015, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

Developing an in-training examination for fellows: the experience of the American Society of Clinical Oncology.

F. Collichio, J. Stewart, D. Adelstein, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Recent randomized trials of chemoradiation in the management of locally advanced head and neck cancer.

D. Adelstein, 1998, Current opinion in oncology.

Identifying an oligometastatic phenotype in HPV-associated oropharyngeal squamous cell cancer: Implications for clinical trial design.

B. Burkey, D. Brickman, L. Rybicki, 2020, Oral oncology.

Rethinking the 10‐pack‐year rule for favorable human papillomavirus–associated oropharynx carcinoma: A multi‐institution analysis

B. Burkey, D. Brickman, B. Moeller, 2020, Cancer.

Locoregional and distant recurrence for HPV-associated oropharyngeal cancer using AJCC 8 staging.

B. Burkey, S. Koyfman, J. Geiger, 2020, Oral oncology.

Predictors of distant metastasis in human papillomavirus–associated oropharyngeal cancer

B. Burkey, C. Reddy, S. Koyfman, 2017, Head & neck.

Regional control is preserved after dose de-escalated radiotherapy to involved lymph nodes in HPV positive oropharyngeal cancer.

B. Burkey, P. Xia, S. Koyfman, 2016, Oral oncology.

Randomized phase III study of 2 cisplatin‐based chemoradiation regimens in locally advanced head and neck squamous cell carcinoma: Impact of changing disease epidemiology on contemporary trial design

B. Burkey, L. Rybicki, S. Koyfman, 2015, Head & neck.

Medical management of head and neck cancers

D. Adelstein, T. Nwizu, 2014 .

Survival trends in head and neck cancer: opportunities for improving outcomes.

D. Adelstein, C. Rodriguez, 2010, The oncologist.

Influence of Treatment Package Time on outcomes in High-Risk Oral Cavity Carcinoma in patients receiving Adjuvant Radiation and Concurrent Systemic Therapy: A Multi-Institutional Oral Cavity Collaborative study.

B. Burkey, N. Lee, N. Dunlap, 2022, Oral oncology.

Human Papillomavirus: Changing Paradigms in Oropharyngeal Cancer

D. Adelstein, C. Rodriguez, David J. Adelstein, 2010, Current oncology reports.

Data Set for the Reporting of Carcinomas of the Nasopharynx and Oropharynx: Explanations and Recommendations of the Guidelines From the International Collaboration on Cancer Reporting.

T. Helliwell, B. O'Sullivan, A. Agaimy, 2018, Archives of pathology & laboratory medicine.

HEAD AND NECK SQUAMOUS CELL CANCER AND THE HUMAN PAPILLOMAVIRUS : SUMMARY OF A NATIONAL CANCER INSTITUTE STATE OF THE SCIENCE MEETING , NOVEMBER

A. Giuliano, A. Chaturvedi, W. Westra, 2009 .

HEAD AND NECK SQUAMOUS CELL CANCER AND THE HUMAN PAPILLOMAVIRUS: SUMMARY OF A NATIONAL CANCER INSTITUTE STATE OF THE SCIENCE MEETING,

A. Giuliano, A. Chaturvedi, W. Westra, 2009 .

Risk of Hematologic Malignancies After Radioiodine Treatment of Well-Differentiated Thyroid Cancer.

J. Maciejewski, H. Carraway, A. Advani, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Reply to A. Piccardo et al, E. Hindié et al, M.C. Kreissl et al, M. Doss, J. Buscombe, R. Fisher, M. Sollini et al, M. Lichtenstein, and M. Tulchinsky et al.

J. Maciejewski, H. Carraway, M. Sekeres, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Multiagent concurrent chemoradiotherapy for locoregionally advanced squamous cell head and neck cancer: mature results from a single institution.

L. Rybicki, M. Strome, R. Esclamado, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A Phase II Study of Perioperative Concurrent Chemotherapy, Gefitinib, and Hyperfractionated Radiation Followed by Maintenance Gefitinib in Locoregionally Advanced Esophagus and Gastroesophageal Junction Cancer

T. Rice, S. Murthy, L. Rybicki, 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

A Phase I Study of the combination of oxaliplatin/docetaxel and vandetanib for the treatment of advanced gastroesophageal cancer

B. Halmos, P. Fu, A. Dowlati, 2013, Investigational New Drugs.

An asterisk indicates reviewers who have evaluated three or more manuscripts in 2012.

David Ball, Ash A. Alizadeh, David A. August, 2013 .

Organ preservation for advanced resectable cancer of the base of tongue and hypopharynx: a Southwest Oncology Group Trial.

M. Leblanc, J. Moon, J. Ensley, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Treatment of head and neck cancer: the role of chemotherapy.

E. Tan, D. Adelstein, P. Lavertu, 1996, Critical reviews in oncology/hematology.

CURRENT CLINICAL ONCOLOGY TM

M. Nevalainen, A. Giordano, R. Pestell, 2008 .

Intended single-modality management of T1 and T2 tonsillar carcinomas: retrospective comparison of radical tonsillectomy vs radiation from a single institution.

R. Seth, R. Esclamado, J. Saxton, 2012, American journal of otolaryngology.

Primary Thyroid Squamous Cell Carcinoma With Complete Response to Radical Surgery and Concurrent Chemoradiotherapy: Diagnostic Pathologic Workup and Clinical Management

S. Koyfman, D. Adelstein, T. Elsheikh, 2019 .

Gender, race, and survival: a study in non-small-cell lung cancer brain metastases patients utilizing the radiation therapy oncology group recursive partitioning analysis classification.

G. Barnett, C. Reddy, M. Vogelbaum, 2009, International journal of radiation oncology, biology, physics.

Radiation Therapy for Oropharyngeal Squamous Cell Carcinoma: American Society of Clinical Oncology Endorsement of the American Society for Radiation Oncology Evidence-Based Clinical Practice Guideline.

J. Waldron, J. Califano, H. Quon, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Stage II esophageal carcinoma: the significance of T and N.

S. Medendorp, J. Goldblum, T. Rice, 1996, The Journal of thoracic and cardiovascular surgery.

The role of surgery in the management of selected patients with small-cell carcinoma of the lung.

D. Ettinger, M. Mckneally, D. Adelstein, 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Concurrent radiation therapy, 5‐fluorouracil, and cisplatin for stage II, III, and IV, node‐negative, squamous cell head and neck cancer. Results and surgical implications

D. Adelstein, A. Earle, A. Shah, 1992, Cancer.

Simultaneous versus sequential combined technique therapy for squamous cell head and neck cancer

D. Adelstein, A. Earle, C. Vlastou, 1990, Cancer.

Long-term survival after chemoradiotherapy for locally advanced squamous cell carcinoma of the esophagus.

D. Adelstein, N. Snow, V. Sharan, 1989, Medical and pediatric oncology.

Endoscopic ultrasound cannot determine suitability for esophagectomy after aggressive chemoradiotherapy for esophageal cancer

S. Medendorp, J. Goldblum, T. Rice, 1999, American Journal of Gastroenterology.

Mature results of a Phase III randomized trial comparing concurrent chemoradiotherapy with radiation therapy alone in patients with Stage III and IV squamous cell carcinoma of the head and neck

M. Secic, M. Strome, J. Saxton, 2000, Cancer.

Clinical Trials in Advanced Unresectable Head and Neck Cancer

D. Adelstein, 2003 .

Maximizing local control and organ preservation in stage IV squamous cell head and neck cancer With hyperfractionated radiation and concurrent chemotherapy.

L. Rybicki, M. Strome, R. Esclamado, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Induction chemotherapy in head and neck cancer.

D. Adelstein, 1999, Hematology/oncology clinics of North America.

Long‐Term Results After Chemoradiotherapy for Locally Confined Squamous‐Cell Head and Neck Cancer

D. Adelstein, A. Earle, C. Vlastou, 1990, American journal of clinical oncology.

Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19805 patients, on behalf of MACH-NC group.

B. Jeremic, L. Collette, J. Pignon, 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Aggressive concurrent chemoradiotherapy for squamous cell head and neck cancer: an 8-year single-institution experience.

M. Secic, M. Strome, J. Saxton, 1999, Archives of otolaryngology--head & neck surgery.

Does induction chemotherapy have a role in the management of locoregionally advanced squamous cell head and neck cancer?

M. Leblanc, D. Adelstein, M. LeBlanc, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Advanced Practice Nurse, Follow-up Clinic Reduces Emergency Room Visits and Admissions in High-Risk Patients After Chemoradiation Therapy for Head and Neck Cancer

S. Koyfman, D. Adelstein, M. Ward, 2015 .

Phase II trial of gefitinib for recurrent or metastatic esophageal or gastroesophageal junction (GEJ) cancer

T. Rice, T. Mekhail, L. Rybicki, 2005 .

Hypomagnesemia and renal magnesium wasting in patients treated with cisplatin.

D. Adelstein, M. Lam, 1986, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Phase I study of WR-2721 and carboplatin.

R. Bukowski, R. Ganapathi, G. Budd, 1993, European journal of cancer.

Randomized trial of carboplatin plus amifostine versus carboplatin alone in patients with advanced solid tumors

T. Olencki, R. Bukowski, R. Ganapathi, 1997, Cancer.

Systemic chemotherapy for squamous cell head and neck cancer

D. Adelstein, 2003, Expert opinion on pharmacotherapy.

Extranodal lymphomas of the head and neck. A 20-year experience.

R. Tubbs, D. Adelstein, J. Wanamaker, 1997, Archives of otolaryngology--head & neck surgery.

Amifostine: potential for clinically useful cytoprotection

T. Olencki, R. Bukowski, R. Ganapathi, 1994, Supportive Care in Cancer.

Treatment of advanced-stage colorectal adenocarcinoma with fluorouracil and high-dose leucovorin calcium: a pilot study.

Y. Rustum, D. Adelstein, J. Hines, 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Bone marrow morphologic changes after combination chemotherapy including VP‐16

D. Adelstein, J. Hines, 1985, Cancer.

High‐dose cytosine arabinoside in previously treated patients with poor‐prognosis non‐Hodgkin's lymphoma

H. Lazarus, D. Adelstein, R. Herzig, 1985, Cancer.

Current and emerging standards of concomitant chemoradiotherapy.

D. Adelstein, C. Rodriguez, 2008, Seminars in oncology.

Treatment of advanced stage mycosis fungoides with bleomycin, doxorubicin, and methotrexate with topical nitrogen mustard (BAM‐M)

D. Adelstein, J. Hines, M. Zakem, 1986, Cancer.

Esophageal carcinoma: esophageal ultrasound assessment of preoperative chemotherapy.

M. Sivak, T. Rice, G. A. Boyce, 1992, The Annals of thoracic surgery.

Comparison of surgical complications after organ-preservation therapy in patients with stage III or IV squamous cell head and neck cancer.

M. Strome, J. Saxton, D. Adelstein, 1998, Archives of otolaryngology--head & neck surgery.

A Reappraisal of Definitive Chemoradiotherapy for Older Adults With Advanced Head and Neck Cancer

Christopher C. Griffith, C. Reddy, S. Koyfman, 2022, AntiCancer Research.

Concurrent Chemoradiotherapy: Impact on Survival and Organ Preservation

D. Adelstein, 2005 .

Oropharyngeal cancer: The role of chemotherapy

D. Adelstein, 2003, Current treatment options in oncology.

Impact of preepiglottic space tumor involvement on concurrent chemoradiation therapy.

R. Esclamado, D. Adelstein, R. Lorenz, 2010, American journal of otolaryngology.

Functional Outcomes Following Chemoradiotherapy for Head and Neck Cancer

P. Elson, J. Chan, M. Strome, 2003, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

Outcomes of Post-Operative Treatment with Concurrent Chemoradiotherapy (CRT) in High-Risk Resected Oral Cavity Squamous Cell Carcinoma (OCSCC): A Multi-Institutional Collaboration

B. Burkey, N. Lee, N. Dunlap, 2021, Current oncology.

Split-Course Accelerated Hypofractionated Radiotherapy (SCAHRT): A Safe and Effective Option for Head and Neck Cancer in the Elderly or Infirm.

B. Burkey, C. Reddy, S. Koyfman, 2016, Anticancer research.

Weekly Low-Dose Versus Three-Weekly High-Dose Cisplatin for Concurrent Chemoradiation in Locoregionally Advanced Non-Nasopharyngeal Head and Neck Cancer: A Systematic Review and Meta-Analysis of Aggregate Data.

L. Licitra, K. Prabhash, J. Vermorken, 2017, The oncologist.

Altered fractionation radiotherapy combined with concurrent low-dose or high-dose cisplatin in head and neck cancer: A systematic review of literature and meta-analysis.

K. Prabhash, J. Vermorken, V. Noronha, 2018, Oral oncology.

Extent of neck dissection required after concurrent chemoradiation for stage IV head and neck squamous cell carcinoma

M. Strome, R. Esclamado, J. Saxton, 2009, Head & neck.

Concurrent chemoradiotherapy in the management of squamous cell cancer of the oropharynx: current standards and future directions.

D. Adelstein, 2007, International journal of radiation oncology, biology, physics.

Induction redux: once more with taxanes.

D. Adelstein, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Simultaneous radiotherapy and chemotherapy with 5-fluorouracil and cisplatin for locally confined squamous cell head and neck cancer.

D. Adelstein, A. Earle, C. Vlastou, 1988, NCI monographs : a publication of the National Cancer Institute.

Hypothyroidism: a frequent event after radiotherapy and after radiotherapy with chemotherapy for patients with head and neck carcinoma.

M. Secic, J. Saxton, D. Adelstein, 2001, Cancer.

Hypothyroidism

M. Secic, J. Saxton, D. Adelstein, 2001 .

Primary Total Laryngectomy versus Organ Preservation for Locally Advanced T3/T4a Laryngeal Cancer

S. Koyfman, J. Geiger, D. Chute, 2022, The Laryngoscope.

Management of the neck in a randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer

M. Secic, M. Strome, J. Saxton, 1997, Head & neck.

Role of clinically determined depth of tumor invasion in the treatment of esophageal carcinoma.

J. Goldblum, E. Blackstone, T. Rice, 2003, The Journal of thoracic and cardiovascular surgery.

Esophageal carcinoma. A six‐year review of the cleveland veterans administration hospital experience

D. Adelstein, W. Forman, B. Beavers, 1984, Cancer.

M1a/M1b esophageal carcinoma: clinical relevance.

J. Goldblum, E. Blackstone, T. Rice, 1999, The Journal of thoracic and cardiovascular surgery.

Role of Treatment Deintensification in the Management of p16+ Oropharyngeal Cancer: ASCO Provisional Clinical Opinion.

Christopher U. Jones, Nofisat Ismaila, Q. Le, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Redefining the role of induction chemotherapy in head and neck cancer.

D. Adelstein, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Enteral nutrition during the treatment of head and neck carcinoma

T. Mekhail, L. Rybicki, J. Saxton, 2001, Cancer.

Concurrent chemoradiotherapy for salvage in relapsed squamous cell head and neck cancer.

E. Tan, J. Saxton, D. Adelstein, 1997, Cancer investigation.

The role of chemotherapy in squamous cell head and neck cancer

D. Adelstein, 2000 .

Integration of chemotherapy into the definitive management of squamous cell head and neck cancer

D. Adelstein, 1999, Current oncology reports.

Pneumonia carcinomatosa from small cell undifferentiated carcinoma of the lung presenting as "reverse radiation pneumonitis".

T. Padhya, J. Tomashefski, D. Adelstein, 1988, Medical and pediatric oncology.

Impact of intensity-modulated radiation therapy on outcomes for malignant pleural mesothelioma treated with trimodality therapy

C. Reddy, T. Rice, S. Murthy, 2014, Journal of Radiation Oncology.

Single‐arm phase II study of multiagent concurrent chemoradiotherapy and gefitinib in locoregionally advanced squamous cell carcinoma of the head and neck

L. Rybicki, J. Saxton, D. Adelstein, 2012, Head & neck.

Continuous Course Radiation Therapy and Concurrent Combination Chemotherapy for Squamous Cell Head and Neck Cancer

H. Tucker, J. Saxton, D. Adelstein, 1994, American journal of clinical oncology.

Differences in autofluorescence spectra of dysplasia and carcinoma arising in barrett's esophagus

T. Rice, G. Zuccaro, R. Cothren, 1995 .

Thromboembolic events in patients with malignant superior vena cava syndrome and the role of anticoagulation

D. Adelstein, S. Carter, John D. Mines, 1988, Cancer.

Intramedullary spinal cord metastasis. Diagnostic and therapeutic considerations.

D. Adelstein, M. Winkelman, N. Karlins, 1987, Archives of neurology.

Image analysis reveals differences in tumor multinucleations in Black and White patients with human papillomavirus‐associated oropharyngeal squamous cell carcinoma

A. Madabhushi, Jun Xu, Patricia D. Castro, 2022, Cancer.

NCCN Guidelines ® Insights Head and Neck Cancers , Version 1 . 2018 Featured Updates to the NCCN Guidelines

R. Weber, A. Jimeno, M. Witek, 2018 .

Oncologic and Functional Outcomes of Surgical and Nonsurgical Treatment of Advanced Squamous Cell Carcinoma of the Supraglottic Larynx.

B. Burkey, L. Rybicki, J. Kaltenbach, 2015, JAMA otolaryngology-- head & neck surgery.

Head and Neck: Editorial

J. J. Coleman, S. Ariyan, L. Delclos, 2001 .

Suboptimal Outcomes in Cutaneous Squamous Cell Cancer of the Head and Neck with Nodal Metastases

B. Burkey, C. Reddy, S. Koyfman, 2018, AntiCancer Research.

Adrenal carcinosarcoma presenting in a woman with clinical signs of virilization. A case report with immunohistochemical and ultrastructural findings.

H. Levin, J. Mcmahon, D. Adelstein, 1992, The American journal of surgical pathology.

Cerebellar toxicity with high-dose cytosine arabinoside.

H. Lazarus, P. Coccia, D. Adelstein, 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

American Society of Clinical Oncology clinical practice guideline for the use of larynx-preservation strategies in the treatment of laryngeal cancer.

K. Ang, G. Weinstein, D. Pfister, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Biology and management of salivary gland cancers.

S. Koyfman, E. Hanna, D. Adelstein, 2012, Seminars in radiation oncology.

What is new in the management of salivary gland cancers?

D. Adelstein, C. Rodriguez, 2011, Current opinion in oncology.

A phase II trial of gefitinib for recurrent or metastatic cancer of the esophagus or gastroesophageal junction

T. Rice, L. Rybicki, D. Adelstein, 2012, Investigational New Drugs.

Use of Larynx-Preservation Strategies in the Treatment of Laryngeal Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update.

G. Weinstein, Nofisat Ismaila, Q. Le, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Immunotherapy of Head and Neck Cancer: summary of a National Cancer Institute Head and Neck Cancer Steering Committee Clinical Trials Planning Meeting, November 9-10, 2014, Bethesda, Maryland

B. Fox, D. Brizel, L. Butterfield, 2016 .

Impact of active smoking on outcomes in HPV+ oropharyngeal cancer

B. Burkey, C. Reddy, S. Koyfman, 2019, Head & neck.

Low-Dose vs. High-Dose Cisplatin: Lessons Learned From 59 Chemoradiotherapy Trials in Head and Neck Cancer

K. Prabhash, J. Vermorken, V. Noronha, 2019, Frontiers in Oncology.

A phase I/II trial of concurrent immunotherapy with chemoradiation in locally advanced larynx cancer

V. Takiar, T. Wise-Draper, K. Redmond, 2022, Laryngoscope investigative otolaryngology.

Tumor Volume Useful Beyond Classic Criteria in Selecting Larynx Cancers For Preservation Therapy

B. Burkey, S. Koyfman, J. Geiger, 2019, The Laryngoscope.

Salvage Laryngectomy in Patients with Recurrent Laryngeal Cancer in the Setting of Nonoperative Treatment Failure

B. Burkey, S. Koyfman, D. Adelstein, 2013, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

Computerized tumor multinucleation index (MuNI) is prognostic in p16+ oropharyngeal carcinoma: A multi-site validation study.

A. Madabhushi, Jun Xu, Patricia D. Castro, 2021, The Journal of clinical investigation.

Malignant Angiomatoid Fibrous Histiocytoma: a separate entity or just the visible part of an iceberg? Case Report of Uncommon Tumor and Brief Review of Literature

D. Adelstein, Amel Tabet-Aoul, M. Aziz, 2020 .

Value of accelerated multimodality therapy in stage IIIA and IIIB non-small cell lung cancer.

E. Blackstone, T. Rice, S. Murthy, 2003, The Journal of thoracic and cardiovascular surgery.

High-dose cytosine arabinoside and mAMSA induction and consolidation in patients with previously untreated de novo acute nonlymphocytic leukemia: Phase I Pilot Study for the Eastern Cooperative Oncology Group.

M. O’connell, J. Bennett, D. Adelstein, 1985, Seminars in oncology.

Syndrome of inappropriate secretion of antidiuretic hormone after infusional vincristine.

D. Adelstein, R. S. Escuro, S. Carter, 1992, Cleveland Clinic journal of medicine.

Cisplatin ototoxicity: the importance of baseline audiometry.

C. Newman, T. Rice, L. Rybicki, 1999, American journal of clinical oncology.

A Phase II Trial of Accelerated Multimodality Therapy for Locoregionally Advanced Cancer of the Esophagus and Gastroesophageal Junction: The Impact of Clinical Heterogeneity

T. Rice, S. Murthy, L. Rybicki, 2007, American journal of clinical oncology.

Use of concurrent chemotherapy, accelerated fractionation radiation, and surgery for patients with esophageal carcinoma

T. Rice, G. Zuccaro, D. Adelstein, 1997, Cancer.

Head and neck squamous cell cancer and the human papillomavirus: Summary of a National Cancer Institute State of the Science Meeting, November 9–10, 2008, Washington, D.C.

A. Giuliano, A. Chaturvedi, W. Westra, 2009, Head & neck.

Superficial esophageal carcinoma.

S. Medendorp, J. Goldblum, T. Rice, 1995, The Annals of thoracic surgery.

Clinicopathologic features and treatment outcomes of patients with human epidermal growth factor receptor 2-positive adenocarcinoma of the esophagus and gastroesophageal junction.

T. Rice, R. Tubbs, L. Rybicki, 2013, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

Concurrent radiation therapy and chemotherapy for locally unresectable squamous cell head and neck cancer: an Eastern Cooperative Oncology Group pilot study.

L. Kalish, M. Oken, S. Remick, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Salvage Laryngectomy Outcomes in Recurrent Laryngeal Cancer

B. Burkey, D. Adelstein, R. Lorenz, 2012 .

Squamous cell head and neck cancer in nonsmokers.

E. Tan, D. Adelstein, P. Lavertu, 1997, American journal of clinical oncology.

Risk Factors Associated with Disease Recurrence in Patients with Stage III/IV Squamous Cell Carcinoma of the Oral Cavity Treated with Surgery and Postoperative Radiotherapy.

B. Burkey, C. Reddy, S. Koyfman, 2016, Anticancer research.

An Imaging Biomarker of Tumor-Infiltrating Lymphocytes to Risk-Stratify Patients With HPV-Associated Oropharyngeal Cancer

A. Madabhushi, Patricia D. Castro, J. Bishop, 2021, Journal of the National Cancer Institute.

Phase II trial of weekly docetaxel and gemcitabine as first-line therapy for patients with advanced non-small cell lung cancer

Mellar P. Davis, T. Mekhail, D. Adelstein, 2006, Medical oncology.

DEFINITIVE MANAGEMENT OF INOPERABLE NON–SMALL CELL LUNG CANCER

T. Mekhail, G. Videtic, D. Adelstein, 2008 .

Does paclitaxel improve the chemoradiotherapy of locoregionally advanced esophageal cancer? A nonrandomized comparison with fluorouracil-based therapy.

J. Ciezki, T. Rice, L. Rybicki, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin's lymphoma.

R. Fisher, T. Grogan, T. Miller, 1998, The New England journal of medicine.

Esophageal carcinoma: depth of tumor invasion is predictive of regional lymph node status.

J. Goldblum, E. Blackstone, T. Rice, 1998, The Annals of thoracic surgery.

Radiation Therapy for Oropharyngeal Squamous Cell Carcinoma : An ASTRO Evidence Based Clinical Practice Guideline

E. Sturgis, R. Tishler, J. Waldron, 2016 .

Adrenal mass evaluation in patients with lung carcinoma: a cost-effectiveness analysis.

N. Obuchowski, M. Baker, T. Rice, 2000, AJR. American journal of roentgenology.

Risk of developing chronic myeloid neoplasms in well-differentiated thyroid cancer patients treated with radioactive iodine

J. Maciejewski, H. Carraway, A. Advani, 2018, Leukemia.

Increased pathologic upstaging with rising time to treatment initiation for head and neck cancer: A mechanism for increased mortality

B. Burkey, Kailin Yang, S. Koyfman, 2018, Cancer.

Multiple myeloma presenting with spinal cord compression.

D. Adelstein, J. Spiess, J. Hines, 1988, Oncology.

Principles of Systemic Chemotherapy for Squamous Cell Head and Neck Cancer

D. Adelstein, C. Rodriguez, 2011 .

Mixed small cell and non-small cell lung cancer.

J. Tomashefski, D. Adelstein, N. Snow, 1986, Chest.

Immunotherapy of head and neck cancer: Emerging clinical trials from a National Cancer Institute Head and Neck Cancer Steering Committee Planning Meeting

B. Fox, B. O'Sullivan, D. Brizel, 2017, Cancer.

Definitive Chemoradiation in Locally Advanced Squamous Cell Carcinoma of the Hypopharynx: Long-term Outcomes and Toxicity

B. Burkey, S. Koyfman, J. Geiger, 2018, AntiCancer Research.

Phase I trial of dipyridamole with 5-fluorouracil and folinic acid.

R. Bukowski, G. Budd, D. Grabowski, 1990, Cancer research.

Validation of the RTOG recursive partitioning analysis (RPA) classification for small-cell lung cancer-only brain metastases.

T. Rice, T. Mekhail, G. Videtic, 2004, International journal of radiation oncology, biology, physics.

Does vocal cord fixation preclude nonsurgical management of laryngeal cancer?

M. Strome, R. Esclamado, J. Saxton, 2009, The Laryngoscope.

Clinical predictors of larynx preservation after multiagent concurrent chemoradiotherapy

L. Rybicki, M. Strome, R. Esclamado, 2008, Head & neck.

Brain metastases from esophageal cancer: a phenomenon of adjuvant therapy?

E. Blackstone, M. Vogelbaum, T. Rice, 2006, The Annals of thoracic surgery.

Treatment of oral squamous cell carcinoma with simultaneous chemotherapy and radiation: results and surgical implications.

D. Adelstein, A. Indresano, A. Earle, 1990, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

Chemoradiotherapy as initial management in patients with squamous cell carcinoma of the head and neck.

D. Adelstein, A. Earle, C. Vlastou, 1986, Cancer treatment reports.

Failure rate in the untreated contralateral node negative neck of small lateralized oral cavity cancers: A multi-institutional collaborative study.

B. Burkey, C. Reddy, N. Dunlap, 2021, Oral oncology.

Refining esophageal cancer staging.

J. Goldblum, E. Blackstone, T. Rice, 2003, The Journal of thoracic and cardiovascular surgery.

Bioavailability of high-dose oral leucovorin.

Y. Rustum, D. Adelstein, M. R. Blum, 1987, NCI monographs : a publication of the National Cancer Institute.

Is there a role for folate determinations in current clinical practice in the USA?

L. Rybicki, E. Hsi, D. Adelstein, 2004, Clinical and laboratory haematology.

Long-term survival of patients with multiple myeloma and acute renal failure at presentation.

H. Lazarus, D. Adelstein, R. Herzig, 1983, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Induction Chemoradiotherapy Increases Pleural and Pericardial Complications after Esophagectomy for Cancer

E. Blackstone, T. Rice, S. Murthy, 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Endoscopic Ultrasound Errors in Esophageal Cancer

J. Goldblum, E. Blackstone, T. Rice, 2005, The American journal of gastroenterology.

Modern Image-Guided Intensity-Modulated Radiotherapy for Oropharynx Cancer and Severe Late Toxic Effects: Implications for Clinical Trial Design.

B. Burkey, C. Reddy, S. Koyfman, 2016, JAMA otolaryngology-- head & neck surgery.

Severe late dysphagia and cause of death after concurrent chemoradiation for larynx cancer in patients eligible for RTOG 91-11.

B. Burkey, S. Koyfman, D. Adelstein, 2016, Oral oncology.

Chapter 33 – Oropharyngeal Cancer

P. Harari, L. Gentry, D. Adelstein, 2016 .

In squamous cell head and neck cancer: which platinum, how much and how often?

D. Adelstein, T. Nwizu, 2014, Expert review of anticancer therapy.

Induction chemotherapy meta-analysis in head and neck cancer: right answer, wrong question.

J. Manola, D. Adelstein, A. Forastiere, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Clinical Factors Associated With Cost in Head and Neck Cancer: Implications for a Bundled Payment Model.

B. Burkey, C. Shah, S. Koyfman, 2019, Journal of oncology practice.

Elucidation of salvage laryngectomy pathologic and clinical variables to guide further treatment intensification investigation

S. Koyfman, D. Adelstein, M. Ward, 2018, The Laryngoscope.

Palliative chemotherapy for non-small cell lung cancer.

D. Adelstein, 1995, Seminars in oncology.

Chemotherapy in the definitive management of oral cancers: Where do we stand today?

J. Geiger, D. Adelstein, 2020, Oral oncology.

Impact of routine surveillance imaging on detecting recurrence in human papillomavirus associated oropharyngeal cancer.

C. Reddy, S. Koyfman, J. Geiger, 2020, Oral oncology.

The prognostic value of pretreatment FDG-PET parameters in HPV-associated oropharynx cancer

B. Burkey, P. Xia, S. Koyfman, 2016, Journal of Radiation Oncology.

Impact of induction concurrent chemoradiotherapy on pulmonary function and postoperative acute respiratory complications in esophageal cancer.

P. Mazzone, T. Rice, T. Mekhail, 2005, Chest.

Advances in the treatment of esophageal carcinoma.

J. Goldblum, T. Rice, G. Falk, 1997, The Gastroenterologist.

Benefit of postoperative adjuvant chemoradiotherapy in locoregionally advanced esophageal carcinoma.

E. Blackstone, T. Rice, S. Murthy, 2003, The Journal of thoracic and cardiovascular surgery.

Clinical trial design in head and neck cancer: what has the oncologist learned?

D. Adelstein, 2012, The Lancet. Oncology.

Impact of age on treatment effect in locally advanced head and neck cancer (HNC): Two individual patient data meta-analyses.

J. Bourhis, M. Saunders, J. Bernier, 2006, Journal of Clinical Oncology.

Evaluating compliance with process‐related quality metrics and survival in oral cavity squamous cell carcinoma: Multi‐institutional oral cavity collaboration study

B. Burkey, N. Lee, N. Dunlap, 2020, Head & neck.

Organ Preservat ion in Stage IV Squamous Cel l Head and Neck Cancer With Hyperfract ionated Radiat ion and Concurrent Chemotherapy

L. Rybicki, M. Strome, R. Esclamado, 2002 .

Prolonged survival after high-dose cytosine arabinoside and amsacrine induction in patients with previously untreated de novo acute nonlymphocytic leukemia.

M. O’connell, J. Bennett, D. Adelstein, 1987, Seminars in oncology.

Detection and Oncologic Outcomes of Head and Neck Squamous Cell Carcinoma of Unknown Primary Origin

B. Burkey, N. Fowler, S. Koyfman, 2020, AntiCancer Research.

Superficial adenocarcinoma of the esophagus.

J. Goldblum, E. Blackstone, T. Rice, 2001, The Journal of thoracic and cardiovascular surgery.

Docetaxel, cisplatin, and fluorouracil induction chemotherapy followed by accelerated fractionation/concomitant boost radiation and concurrent cisplatin in patients with advanced squamous cell head and neck cancer: A Southwest Oncology Group phase II trial (S0216)

J. Moon, G. Wolf, E. Hanna, 2009, Head & neck.

Multi‐agent concurrent chemoradiotherapy for locally advanced head and neck squamous cell cancer in the elderly

J. Saxton, D. Adelstein, C. Rodriguez, 2012, Head & neck.

Case Report: Primary Orbital Squamous Cell Carcinoma

Arun D. Singh, S. Koyfman, D. Adelstein, 2018, Ocular Oncology and Pathology.

Overexpression of p53 protein associates decreased response to chemoradiotherapy in patients with esophageal carcinoma.

J. Goldblum, T. Rice, L. Rybicki, 1999, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

A phase III randomized trial of two cisplatin-based concurrent chemoradiation (CCRT) regimens for locally advanced head and neck squamous cell carcinoma (LAHNSCC).

B. Burkey, L. Rybicki, S. Koyfman, 2013 .

N1 esophageal carcinoma: the importance of staging and downstaging.

J. Goldblum, E. Blackstone, T. Rice, 2001, The Journal of thoracic and cardiovascular surgery.

Cost-effectiveness of nivolumab for recurrent or metastatic head and neck cancer☆.

C. Shah, S. Koyfman, J. Geiger, 2017, Oral oncology.

Predictive value of clinical factors through restaging after induction concurrent chemoradiotherapy for locoregionally advanced adenocarcinoma of the esophagus and gastroesophageal junction

T. Rice, S. Murthy, L. Rybicki, 2013 .

Aggressive multimodality therapy for malignant pleural mesothelioma.

T. Rice, H. Wiedemann, D. Adelstein, 1994, The Annals of thoracic surgery.

Mature Results from a Phase II Trial of Postoperative Concurrent Chemoradiotherapy for Poor Prognosis Cancer of the Esophagus and Gastroesophageal Junction

T. Rice, S. Murthy, L. Rybicki, 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Squamous cell head and neck cancer [9]

M. McGurk, D. Adelstein, 2005 .

Gefitinib in definitive management of esophageal or gastroesophageal junction cancer: a retrospective analysis of two clinical trials.

T. Rice, S. Murthy, R. Tubbs, 2015, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

It is not just IMRT: Human papillomavirus related oropharynx squamous cell carcinoma is associated with better swallowing outcomes after definitive chemoradiotherapy.

B. Burkey, L. Rybicki, S. Koyfman, 2015, Oral oncology.

Impaired vocal cord mobility in T2N0 glottic carcinoma: Suboptimal local control with Radiation alone

B. Burkey, C. Reddy, S. Koyfman, 2016, Head & neck.

Importance of residual primary cancer after induction therapy for esophageal adenocarcinoma.

John Ehrlinger, Eugene H Blackstone, J. Goldblum, 2016, The Journal of thoracic and cardiovascular surgery.

T2N0M0 esophageal cancer.

E. Blackstone, T. Rice, S. Murthy, 2007, The Journal of thoracic and cardiovascular surgery.

NCCN Guidelines Insights: Head and Neck Cancers, Version 2.2017.

J. Shah, R. Weber, A. Jimeno, 2017, Journal of the National Comprehensive Cancer Network : JNCCN.

NCCN Guidelines Insights: Head and Neck Cancers, Version 1.2018.

R. Weber, A. Jimeno, M. Witek, 2018, Journal of the National Comprehensive Cancer Network : JNCCN.

Precise clinical staging allows treatment modification of patients with esophageal carcinoma.

T. Rice, D. Adelstein, 1997, Oncology.

The role of chemotherapy in the primary management of nasopharyngeal cancer

D. Adelstein, 2000 .

Outcomes of postoperative treatment with concurrent chemoradiotherapy (CRT) in high risk resected oral cavity squamous cell carcinoma (OCSCC): A multi-institutional collaboration.

B. Burkey, N. Lee, N. Dunlap, 2019, Journal of Clinical Oncology.

Diffuse well differentiated lymphocytic lymphoma: a clinical study of 22 patients.

D. Adelstein, J. Hines, L. Bowman, 1991, Oncology.

American Society of Clinical Oncology clinical practice guideline for the use of larynx-preservation strategies in the treatment of laryngeal cancer.

G. Weinstein, W. Mendenhall, L. Harrison, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Choice of Radiotherapy Planning Modality Influences Toxicity in the Treatment of Locally Advanced Esophageal Cancer

Jonathan S. Adelstein, C. Reddy, T. Rice, 2008, Journal of gastrointestinal cancer.

Current Developments in the Management of Locally Advanced Esophageal Cancer

D. Adelstein, M. Mcnamara, 2012, Current Oncology Reports.

Utility of positron emission tomography compared with mediastinoscopy for delineating involved lymph nodes in stage III lung cancer: insights for radiotherapy planning from a surgical cohort.

T. Rice, S. Murthy, T. Mekhail, 2008, International Journal of Radiation Oncology, Biology, Physics.

The community approach to salvage therapy for advanced head and neck cancer.

D. Adelstein, 1994, Seminars in oncology.

Prognostic value of computed tomography scan detection of cartilage invasion in advanced laryngeal cancer treated with primary total laryngectomy

B. Burkey, S. Koyfman, J. Geiger, 2022, Head & neck.

Oncologic and Functional Outcomes of Surgical and Nonsurgical Treatment of Advanced Squamous Cell Carcinoma of the Supraglottic Larynx.

B. Burkey, L. Rybicki, J. Kaltenbach, 2015, JAMA otolaryngology-- head & neck surgery.

Does vocal cord fixation preclude nonsurgical management of laryngeal cancer?

M. Strome, R. Esclamado, J. Saxton, 2009, The Laryngoscope.

Corynebacterium JK: a cause of nosocomial device-related infection.

D. Adelstein, P. Spagnuolo, N. Frantz, 1986, Reviews of infectious diseases.

Multiagent concurrent chemoradiotherapy (MACCRT) and gefitinib in locoregionally advanced head and neck squamous cell cancer (HNSCC).

L. Rybicki, J. Saxton, D. Adelstein, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Studies on a family with combined functional deficiencies of vitamin K-dependent coagulation factors.

B. Furie, D. Adelstein, G. Goldsmith, 1982, The Journal of clinical investigation.